Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Open-market buy Director bought 10,000 shares at $26.43 ($264,269)
  2. 4 Open-market sale SVP, CLO, Alkermes, Inc. sold 14,000 shares at $26.00 ($364,000)
  3. 4 Open-market sale Director sold 20,000 shares at $24.58 ($491,504)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale SVP, CLO, Alkermes, Inc. sold 13,500 shares at $25.00 ($337,500)
  15. 4 Open-market sale Director sold 25,000 shares at $25.00 ($625,000)
  16. 4 Open-market sale EVP R&D, Chief Medical Officer sold 882 shares at $24.60 ($21,697)
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 368 shares (to pay taxes)
  19. 4 Open-market sale SVP, CLO, Alkermes, Inc. sold 13,500 shares at $24.00 ($324,000)
  20. 4 Open-market sale Director sold 5,000 shares at $24.00 ($120,000)

Page 16 of 67 · 1,323 filings